Tuesday, May 12, 2020

India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...

from NDTV News - Latest https://ift.tt/3bqUqQ1
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Loops, Rolls, Tricolor Sky: Air Force's Suryakiran Show Set For Somnath Debut

The skies over the first Jyotirlinga, Somnath, are set to host a breathtaking display of aerial precision as the Indian Air Force (IAF) debu...